SCHEMBL2457593

SCHEMBL2457593

O=c1c(Cc2cccc(Cl)c2)c(CO)[nH]c2ncnn12

nearest known ligand 0.43

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
ENPP1 P22413 1/20 0.43
CCR2 P41597 5/20 0.40
ALKBH3 Q96Q83 1/20 0.39
PDE1B Q01064 3/20 0.39
DAO P14920 1/20 0.38
HCAR2 Q8TDS4 1/20 0.38
CCR5 P51681 1/20 0.37
KDM4A O75164 1/20 0.37
KDM4C Q9H3R0 1/20 0.37
KDM5B Q9UGL1 1/20 0.37
LMNA P02545 1/20 0.37
POLB P06746 1/20 0.37
PDE5A O76074 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2459450 0.86 ENPP1 (0.47) ENPP1CCR2ALKBH3PDE1BDAO
SCHEMBL2462884 0.86 ENPP1 (0.44) ENPP1CCR2ALKBH3PDE1BDAO
SCHEMBL2455177 0.85 NR3C1 (0.46) ENPP1CCR2ALKBH3PDE1BDAO
SCHEMBL2461078 0.84 ENPP1 (0.42) ENPP1CCR2ALKBH3PDE1BCCR5
SCHEMBL2455657 0.84 ENPP1 (0.50) ENPP1CCR2ALKBH3PDE1BDAO
SCHEMBL2457283 0.82 ENPP1 (0.46) ENPP1CCR2ALKBH3PDE1BCCR5
SCHEMBL2461260 0.81 CCR2 (0.48) ENPP1CCR2ALKBH3PDE1BDAO
SCHEMBL2462543 0.81 ENPP1 (0.45) ENPP1CCR2ALKBH3PDE1BDAO
SCHEMBL2429495 0.81 ENPP1 (0.43) ENPP1CCR2ALKBH3PDE1BDAO
SCHEMBL2458532 0.81 ENPP1 (0.45) ENPP1CCR2ALKBH3PDE1BDAO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011114148-A1 4H- [1, 2, 4] TRIAZOLO [5, 1 -B] PYRIMIDIN-7 -ONE DERIVATIVES AS CCR2B RECEPTOR ANTAGONISTS ASTRAZENECA AB (SE) 2011-09-22 WO disclosed
WO-2011114148-A1 4H- [1, 2, 4] TRIAZOLO [5, 1 -B] PYRIMIDIN-7 -ONE DERIVATIVES AS CCR2B RECEPTOR ANTAGONISTS ASTRAZENECA AB (SE) 2011-09-22 WO disclosed